701 related articles for article (PubMed ID: 21612563)
1. Characteristics and specificities of Cryptococcus infections in French Guiana, 1998-2008.
Debourgogne A; Iriart X; Blanchet D; Veron V; Boukhari R; Nacher M; Carme B; Aznar C
Med Mycol; 2011 Nov; 49(8):864-71. PubMed ID: 21612563
[TBL] [Abstract][Full Text] [Related]
2. Clinical and microbiological characteristics of cryptococcosis in Singapore: predominance of Cryptococcus neoformans compared with Cryptococcus gattii.
Chan M; Lye D; Win MK; Chow A; Barkham T
Int J Infect Dis; 2014 Sep; 26():110-5. PubMed ID: 25018090
[TBL] [Abstract][Full Text] [Related]
3. Cryptococcosis in Colombia: results of the national surveillance program for the years 2006-2010.
Escandón P; de Bedout C; Lizarazo J; Agudelo CI; Tobón A; Bello S; Restrepo A; Castañeda E;
Biomedica; 2012 Sep; 32(3):386-98. PubMed ID: 23715187
[TBL] [Abstract][Full Text] [Related]
4. Cryptococcosis.
Gushiken AC; Saharia KK; Baddley JW
Infect Dis Clin North Am; 2021 Jun; 35(2):493-514. PubMed ID: 34016288
[TBL] [Abstract][Full Text] [Related]
5. Clinical insights and epidemiology of central nervous system infection due to Cryptococcus neoformans/gattii species complexes: A prospective study from South India.
Lahiri S; Manjunath N; Bhat M; Hagen F; Bahubali VH; Palaniappan M; Maji S; Chandrashekar N
Med Mycol; 2020 Jul; 58(5):600-608. PubMed ID: 31578566
[TBL] [Abstract][Full Text] [Related]
6. Differentiation of Cryptococcus neoformans varieties and Cryptococcus gattii using CAP59-based loop-mediated isothermal DNA amplification.
Lucas S; da Luz Martins M; Flores O; Meyer W; Spencer-Martins I; Inácio J
Clin Microbiol Infect; 2010 Jun; 16(6):711-4. PubMed ID: 19694768
[TBL] [Abstract][Full Text] [Related]
7. [Cryptococcosis caused by Cryptococcus neoformans var. Gattii. A case associated with acquired immunodeficiency syndrome (AIDS) in Kinshasa, Zaire].
Muyembe Tamfum JJ; Mupapa Kibadi D; Nganda L; Ngwala-Bikindu D; Kuezina T; Kela-We I; Vandepitte J
Med Trop (Mars); 1992; 52(4):435-8. PubMed ID: 1494313
[TBL] [Abstract][Full Text] [Related]
8. [Cryptococcus neoformans chemotyping. Review of the literature. New epidemiologic data on cryptococcosis. Our experience with the use of C.G.B. media in the study of this yeast].
de Melo NT; Lacaz Cda S; Charbel CE; Pereira AD; Heins-Vaccari EM; França-Netto AS; Machado Ldos R; Livramento JA
Rev Inst Med Trop Sao Paulo; 1993; 35(5):469-78. PubMed ID: 8115818
[TBL] [Abstract][Full Text] [Related]
9. Experimental systemic infection with Cryptococcus neoformans var. grubii and Cryptococcus gattii in normal and immunodeficient mice.
Capilla J; Maffei CM; Clemons KV; Sobel RA; Stevens DA
Med Mycol; 2006 Nov; 44(7):601-10. PubMed ID: 17071553
[TBL] [Abstract][Full Text] [Related]
10. Systemic fungal infections in patients with human inmunodeficiency virus.
Rodríguez-Cerdeira C; Arenas R; Moreno-Coutiño G; Vásquez E; Fernández R; Chang P
Actas Dermosifiliogr; 2014; 105(1):5-17. PubMed ID: 23107866
[TBL] [Abstract][Full Text] [Related]
11. Epidemiological, Clinical and Outcome Aspects of Patients with Cryptococcosis Caused by Cryptococcus gattii from a Non-endemic Area of Brazil.
Damasceno-Escoura AH; de Souza ML; de Oliveira Nunes F; Pardi TC; Gazotto FC; Florentino DH; Mora DJ; Silva-Vergara ML
Mycopathologia; 2019 Feb; 184(1):65-71. PubMed ID: 30415450
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology of cryptococcosis in Malaysia.
Tay ST; Rohani MY; Hoo TS; Hamimah H
Mycoses; 2010 Nov; 53(6):509-14. PubMed ID: 19627508
[TBL] [Abstract][Full Text] [Related]
13. Molecular analysis of 311 Cryptococcus neoformans isolates from a 30-month ECMM survey of cryptococcosis in Europe.
Viviani MA; Cogliati M; Esposto MC; Lemmer K; Tintelnot K; Colom Valiente MF; Swinne D; Velegraki A; Velho R;
FEMS Yeast Res; 2006 Jun; 6(4):614-9. PubMed ID: 16696657
[TBL] [Abstract][Full Text] [Related]
14. Characterization of clinical isolates of the Cryptococcus neoformans-Cryptococcus gattii species complex from the Amazonas State in Brazil.
Da Silva BK; Freire AK; Bentes Ados S; Sampaio Ide L; Santos LO; Dos Santos MS; De Souza JV
Rev Iberoam Micol; 2012; 29(1):40-3. PubMed ID: 21699993
[TBL] [Abstract][Full Text] [Related]
15. Method for identification of Cryptococcus neoformans and Cryptococcus gattii useful in resource-limited settings.
Ogundeji AO; Albertyn J; Pohl CH; Sebolai OM
J Clin Pathol; 2016 Apr; 69(4):352-7. PubMed ID: 26598625
[TBL] [Abstract][Full Text] [Related]
16. [CAP59 gene amplification in Cryptococcus neoformans and Cryptococcus gattii directly from a yeast suspension].
Siachoque N; Jewtuchowicz VM; Iovannitti C; Mujica MT
Rev Argent Microbiol; 2010; 42(2):91-4. PubMed ID: 20589327
[TBL] [Abstract][Full Text] [Related]
17. Molecular typing and antifungal susceptibility of clinical and environmental Cryptococcus neoformans species complex isolates in Goiania, Brazil.
Souza LK; Souza Junior AH; Costa CR; Faganello J; Vainstein MH; Chagas AL; Souza AC; Silva MR
Mycoses; 2010 Jan; 53(1):62-7. PubMed ID: 19500261
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment of Cryptococcus gattii neurocryptococcosis in a 5-year-old immunocompetent child from the French Guiana Amazon region.
Debourgogne A; Hagen F; Elenga N; Long L; Blanchet D; Veron V; Lortholary O; Carme B; Aznar C
Rev Iberoam Micol; 2012; 29(4):210-3. PubMed ID: 22366716
[TBL] [Abstract][Full Text] [Related]
19. [The epidemiological characteristics of 105 cases of cryptococcosis diagnosed in the Republic of Argentina between 1981-1990].
Bava AJ; Negroni R
Rev Inst Med Trop Sao Paulo; 1992; 34(4):335-40. PubMed ID: 1342091
[TBL] [Abstract][Full Text] [Related]
20. Retrospective study of the epidemiology and clinical manifestations of Cryptococcus gattii infections in Colombia from 1997-2011.
Lizarazo J; Escandón P; Agudelo CI; Firacative C; Meyer W; Castañeda E
PLoS Negl Trop Dis; 2014; 8(11):e3272. PubMed ID: 25411779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
